| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 08/31/2004 | US6784197 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/31/2004 | US6784192 Na+ channel inhibitory action is useful for therapy and prevention for example, arrhythmia, various neuralgias and analgesic |
| 08/31/2004 | US6784189 Potassium channel inhibitors and method |
| 08/31/2004 | US6784181 Ligands for the delta receptor |
| 08/31/2004 | US6784180 Piperidines derivatives and their use as serotonin receptor antagonists |
| 08/31/2004 | US6784173 Aromatic dicarboxylic acid derivatives |
| 08/31/2004 | US6784167 17-beta-hydroxysteroid dehydrogenase-II inhibitors |
| 08/31/2004 | US6784137 6-aryl-4-aminopicolinates and their use as herbicides |
| 08/26/2004 | WO2004072101A2 Phenylglycine derivatives useful as serine protease inhibitors |
| 08/26/2004 | WO2004072060A1 Substituted 3-(benzoylureido)-thiophene derivatives, method for the production and use thereof |
| 08/26/2004 | WO2004072034A1 Piperidine-benzenesulfonamide derivatives |
| 08/26/2004 | WO2004072031A2 Phenylacetamides and their use as glucokinase modulators |
| 08/26/2004 | WO2004072025A2 Substituted n-arylheterocycles, method for production and use thereof as medicaments |
| 08/26/2004 | WO2004071460A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/26/2004 | WO2004071428A2 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 08/26/2004 | WO2004071390A2 Piperazine-2-carboxamide derivatives |
| 08/26/2004 | WO2004058702A3 4-[(4-(carboxyethyl) piperidinyl) methyl] pyrrolidines as modulators of chemokine receptor activity |
| 08/26/2004 | WO2004050610A3 Modulators of melanocortin receptor |
| 08/26/2004 | WO2004018461A3 Antibacterial benzoic acid derivatives |
| 08/26/2004 | WO2004018438A3 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives |
| 08/26/2004 | US20040167341 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 08/26/2004 | US20040167334 Heterocyclic acylsulfimides, processes for their preparation, compositions comprising them and their use as pesticides |
| 08/26/2004 | US20040167193 Fungicides |
| 08/26/2004 | US20040167182 Hydroxamic acid and amide compounds and their use as protease inhibitors |
| 08/26/2004 | US20040167176 Tricyclic compounds useful as angiotensin II agonists |
| 08/26/2004 | US20040167171 Prevention, therapy of neurodegenerative disease; diffusion through brain, blood barrier; Alzheimer's, Parkinson's Huntington's diseases, Amyotrophic lateral sclerosis |
| 08/26/2004 | US20040167167 Biphenyl derivatives |
| 08/26/2004 | US20040167166 Amino-piperidine derivatives |
| 08/26/2004 | US20040167158 Heterocyclic compounds for the treatment of migraine |
| 08/26/2004 | US20040167155 Treating atherosclerosis, myocardial infarction, congestive heart failure, inflammatory bowel disease, arthritis, diabetes and autoimmune diseases |
| 08/26/2004 | US20040167142 Pyrimidinone compounds |
| 08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 08/26/2004 | US20040167129 Novel CB 1 receptor inverse agonists |
| 08/26/2004 | US20040167127 atherosclerosis; antiarthritic agents; antidiabetic agents; cardiovascular disorders; autoimmune diseases; multiple sclerosis; chronic obstructive pulmonary disease |
| 08/26/2004 | US20040167122 Central nervous system disorders; anxiolytic agents; neurodegenerative disorders; obsessive compulsive disorders; schizophrenia; antidepressants; alzheimer's disease; neuropathic pain; stroke |
| 08/26/2004 | US20040167121 Indazolinone compositions useful as kinase inhibitors |
| 08/26/2004 | US20040167120 Novel Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases |
| 08/26/2004 | US20040167118 Novel diarylalkene derivatives and novel diarylalkane derivatives |
| 08/26/2004 | US20040167116 Viricides |
| 08/26/2004 | US20040166363 Chemical compound capable of emitting visible light, and luminescent material, electro-luminescent device, and display apparatus that contain the chemical compound |
| 08/26/2004 | CA2516269A1 Substituted 3-(benzoylureido)-thiophene derivatives, method for the production and use thereof |
| 08/26/2004 | CA2516118A1 Substituted n-arylheterocycles, method for production and use thereof as medicaments |
| 08/26/2004 | CA2515838A1 Piperidine-benzenesulfonamide derivatives |
| 08/26/2004 | CA2515670A1 Phenylacetamides and their use as glucokinase modulators |
| 08/26/2004 | CA2515631A1 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 08/26/2004 | CA2513716A1 Piperazine-2-carboxamide derivatives |
| 08/25/2004 | EP1449841A1 New fungicidal compounds |
| 08/25/2004 | EP1449835A2 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds |
| 08/25/2004 | EP1449834A2 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 08/25/2004 | EP1448577A1 Rhodium and iridium complexes |
| 08/25/2004 | EP1448566A2 Chemokine receptor antagonists and methods of use thereof |
| 08/25/2004 | EP1448561A1 Beta 3 adrenergic agonists |
| 08/25/2004 | EP1448556A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) |
| 08/25/2004 | EP1448555A1 Pyridine and pyrimidine derivatives |
| 08/25/2004 | EP1448553A1 N-heterocyclyl hydrazides as neurotrophic agents |
| 08/25/2004 | EP1448548A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448546A1 Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake |
| 08/25/2004 | EP1448539A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 08/25/2004 | EP1448535A1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 08/25/2004 | EP1448534A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition ofthe coagulation cascade |
| 08/25/2004 | EP1448526A1 Piperidine-based mch antagonists for treatment of obesity and cns disorders |
| 08/25/2004 | EP1448525A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 08/25/2004 | EP1448524A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448200A2 (4-phenyl)piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 08/25/2004 | EP1448199A1 Benzimidazoles useful as protein kinase inhibitors |
| 08/25/2004 | EP1087963B1 Inhibitors of glycogen synthase kinase 3 |
| 08/25/2004 | EP1086080B1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 08/25/2004 | EP0973769B1 Process for preparing eprosartan |
| 08/25/2004 | EP0883616B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/25/2004 | CN1524079A Novel sulfamides and their use as endothelin receptor antagonists |
| 08/25/2004 | CN1524078A Antagonists of mcp-1 function and methods of use thereof |
| 08/25/2004 | CN1524075A Substitued arylketones |
| 08/25/2004 | CN1523989A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/25/2004 | CN1523988A Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 08/25/2004 | CN1522701A Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy |
| 08/25/2004 | CN1163495C Pyridine compounds, preparation method thereof and pharmaceutical compositions containing them |
| 08/25/2004 | CN1163484C 4-Aroyl-Piperidin-CCR-3 receptor antagonist III |
| 08/24/2004 | US6780996 Process for the preparation of 7-substituted-3 quinolinecarbonitriles |
| 08/24/2004 | US6780883 Anticholesterol agents; cardiovascular disorders; antilipemic agents; restenosis; dietetics |
| 08/24/2004 | US6780879 As antitumor agent |
| 08/24/2004 | US6780878 Antithrombotic amides |
| 08/24/2004 | US6780876 Composition for keeping away vermin |
| 08/24/2004 | US6780874 Autoimmune disease; antiinflammatory agents; antiproliferative agent |
| 08/24/2004 | US6780870 Treatment of the pain (both chronic and acute), fever and inflammation of a variety of conditions and diseases mediated by cox-2 |
| 08/24/2004 | US6780859 For therapy of diabetes, obesity, impaired glucose tolerance, gastrointestinal disorders, hypertriglyceridemia, hypercholesteolemia, atherosclerotic disorders, or cardiovascular disorders |
| 08/24/2004 | US6780477 Liquid crystalline compounds |
| 08/19/2004 | WO2004069831A1 Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation |
| 08/19/2004 | WO2004069830A1 Triazole compounds and the therapeutic use thereof |
| 08/19/2004 | WO2004069826A1 Malonamide derivatives as gamma-secretase inhibitors |
| 08/19/2004 | WO2004069823A1 Inhibitors of histone deacetylase |
| 08/19/2004 | WO2004069810A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 08/19/2004 | WO2004069809A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 08/19/2004 | WO2004069801A1 Metal ion chelators and therapeutic use thereof |
| 08/19/2004 | WO2004069793A2 Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| 08/19/2004 | WO2004069792A2 Quinoline-derived amide modulators of vanilloid vr1 receptor |
| 08/19/2004 | WO2004069788A1 Carboxylic acid compounds |
| 08/19/2004 | WO2004069139A2 4-aminopyrimidin-5-yl-methanone derivatives for inhibition of cdk4 activity |
| 08/19/2004 | WO2004058717A8 Isoquinolinone derivatives and their use as therapeutic agents |
| 08/19/2004 | WO2004056365A3 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
| 08/19/2004 | WO2004041201A3 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |